Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vornorexant (ORN-0829; TS-142) is a potent dual OX1R and OX2R antagonist with IC 50 values of 1.05 nM and 1.27 nM, respectively. Vornorexant exhibits potent sleep-promoting effects in vivo and can be used for insomnia treatment research.
説明 | Vornorexant (ORN-0829; TS-142) is a potent dual OX1R and OX2R antagonist with IC 50 values of 1.05 nM and 1.27 nM, respectively. Vornorexant exhibits potent sleep-promoting effects in vivo and can be used for insomnia treatment research. |
In vivo | Vornorexant, when administered orally to rats at dosages ranging from 1 to 10 mg/kg, demonstrates significant sleep-inducing and sleep-promoting effects, as evidenced by a dose-dependent increase in total sleep percentage observed in a rat polysomnogram study at a 1 mg/kg dose. Additionally, Vornorexant displays favorable pharmacokinetic characteristics, characterized by a swift maximum concentration (T max) and brief elimination half-lives in both rats and dogs, with half-lives of 0.238 hours in rats and 1.16 hours in dogs. Administered to rats before the onset of their active phase (prior to lights off), the compound has shown promising efficacy in sleep enhancement at dosages of 1, 3, and 10 mg/kg. |
別名 | ORN-0829, TS-142 |
分子量 | 447.474 |
分子式 | C23H22FN7O2 |
CAS No. | 1517965-94-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vornorexant 1517965-94-4 ORN0829 ORN-0829 TS142 TS-142 TS 142 ORN 0829 Inhibitor inhibitor inhibit